Minneapolis VA Health Care System
Minneapolis, Minnesota, 55417, United States
NCT Number: NCT01469104
The investigators hypothesis is that a carbohydrate-free diet, ingested for 3 days, results in a change in blood glucose that is similar to the change observed after 3 days of fasting.
Looking for future studies?
Notify Me45 year–75 year
All sexes
Interventional
Not applicable
Minneapolis, Minnesota, 55417, United States
In addition to plasma glucose concentrations, other hormones and metabolites known to be affected by fasting will be measured. These include insulin and glucagon, which are hormones that have an important role in regulating fuel use in the body.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will fast for 72 hours
Other names: 3-Day Fast
Subjects will receive a carbohydrate-free diet for 72 hours
Other names: Carbohydrate-free diet
Time frame: 24 hour profile:before and after meals, or traditional meal times
Time frame: 24 hour profiles: before and after meals or traditional meal times
Minneapolis Veterans Affairs Medical Center
Fed
Acronym: CHO-free diet
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04639414
Diabetes Mellitus, Diabetes Mellitus, Type 2
Graz, Austria
View Trial DetailsNCT04734015
Diabetes Mellitus, Diabetes Mellitus, Type 2
Duluth, Minnesota, United States
View Trial DetailsNCT05648383
Body Weight, Cardiovascular Diseases
Tirana, Rruga E Dibrës, Albania
View Trial DetailsNCT07587151
Diabetes Mellitus, Diabetes Mellitus, Type 2
Rockford, Illinois, United States
View Trial Details